Taking the Pulse

📢“If they have anything that’s going on, they’re unafraid to say ‘Hey, something just doesn’t feel right...” ⚕️Hear how Coach @DawnStaley protected player mental health while @GamecockWBB took home the National Championship in the national spotlight at takingthepulsehealthcast.com!

This episode we welcome John Erwin, the newest addition to @maynardnexsen, to discuss the landscape of M&A in the life sciences industry. 🔊Tune in for a look at how transactional strategy is adapting and what may lie ahead for life sciences: open.spotify.com/show/5iALGRluQ…

Leslie Isenhour is helping shape the future of life sciences talent through her leadership at @waketechcc, working closely with industry partners to build training pathways that prepare students for careers in biopharmaceutical manufacturing. 🌐 thepulsehealthcast.com

🧪This episode we welcome Dean Leslie Isenhour of @waketechcc. With the growing demand for life sciences talent, Dean Isenhour shares how Wake Take is preparing the community through customized training programs, apprenticeships, & early exposure. Tune in: thepulsehealthcast.com

As technology reshapes biopharmaceutical manufacturing, workforce development must evolve alongside it. On this episode, John Balchunas discusses how AI & digital skills are changing the way employers train the next generation of life sciences talent. 🌐 thepulsehealthcast.com

Meet this episode’s guest: John Balchunas, Workforce Director at @NIIMBL. John shares insight into how the life sciences industry is approaching workforce and talent development + how employers are rethinking skills and training as technology evolves. 🌐thepulsehealthcast.com

🧪Recorded at the @SCBiotech Conference, we welcome John Balchunas, Workforce Director at @NIIMBL. 🔊Tune in for a look at how organizations are working to future-proof the workforce behind advanced manufacturing and life sciences innovation: open.spotify.com/show/5iALGRluQ…

📢 “[The] tumor is gone… and they’re all durable responses.” — Dr. Besim Ogretmen, Co‑Founder & CEO of Lipo‑Immuno Tech and researcher at @MUSChealth 🔊 Hear more about novel cancer treatments and stream episode 274 now: open.spotify.com/show/5iALGRluQ… 🌐 thepulsehealthcast.com

🎙️Meet Dr. Besim Ogretmen, an internationally recognized cancer researcher at @MUSChealth. Dr. Ogretmen discusses his mission of developing chemoimmunotherapy approaches aimed at improving outcomes for patients with advanced cancers. Listen at thepulsehealthcast.com!

Meet Christin Carey, @maynardnexsen's newest FDA‑focused life sciences attorney. She shares insight on how regulatory shifts & recent tariffs are impacting pharma, biotech, medical devices, and digital health. 🌐 Listen to episode 273 at thepulsehealthcast.com

On April 2, the Trump Administration imposed a 100% tariff on many imported, branded drugs. @maynardnexsen attorney Christin Carey explains why these new tariffs raise critical @US_FDA compliance questions for mid-size pharma and biotech companies. 🌐 thepulsehealthcast.com

🧪Christin Carey, @maynardnexsen's newest @US_FDA-focused life sciences attorney, discusses regulatory developments shaping the life sciences & digital health industries. Tune in for guidance on navigating regulation while developing innovative products: open.spotify.com/show/5iALGRluQ…

🎙️On episode 272, we're joined by Dr. Joseph Scalea, a nationally recognized transplant surgeon at @MUSChealth. Dr. Scalea shares his “Four Reasons to Live” framework and why reconnecting with purpose matters for both patients and providers. 🌐 Listen at thepulsehealthcast.com

Recorded at @SCBiotech 2026, we welcome @MUSChealth's Dr. Joseph Scalea, a nationally recognized transplant surgeon & academic leader. Dr. Scalea shares his “Four Reasons to Live” framework and how understanding a patient’s purpose influences outcomes. 🌐thepulsehealthcast.com

This episode we welcome Ken Webb, Co‑Founder of NeuroHope Therapeutics. Ken shares how his research led to the launch of NeuroHope Therapeutics, which focuses on developing drug‑delivery technologies for spinal cord and traumatic brain injuries. 🌐 thepulsehealthcast.com

Ken Webb of NeuroHope Therapeutics discusses how scaling drug‑delivery requires rigorous quality control and the right manufacturing partners to support the transition toward clinical trials. 🔊 Stream episode 271 now: open.spotify.com/show/5iALGRluQ… 🌐thepulsehealthcast.com

🧪Recorded at the @SCBiotech Conference, we welcome @ClemsonUniv's Ken Webb, Co‑Founder & President of NeuroHope Therapeutics. Ken shares how his team is developing & commercializing novel technologies aimed at treating central nervous system trauma. 🔊thepulsehealthcast.com

“We really have put a lot of emphasis and efforts toward developing our workforce.” Daniel Grove of @LonzaGroup, shares how Lonza prioritizes workforce development and leadership training to build engaged teams and prepare for the future. 🌐 thepulsehealthcast.com

On episode 270, we welcome Daniel Grove, Director of HR at @LonzaGroup. He shares how Lonza approaches talent development and connects employees to the purpose behind life‑changing treatments. 🔊 Stream episode 270 now: open.spotify.com/show/5iALGRluQ… 🌐 thepulsehealthcast.com

Recorded at @SCBiotech 2026, we welcome Daniel Grove, Director of HR at @LonzaGroup, who shares insights into workforce challenges facing life sciences manufacturing. 🔊Tune in for a thoughtful conversation on building teams that thrive in life sciences: open.spotify.com/show/5iALGRluQ…

🎙️Meet Gordon Maner, this week's guest and Partner at Frontline Healthcare Partners. Gordon brings a unique perspective to healthcare investing, with a career spanning investment banking, wealth management, and private equity. 🔊 Stream episode 269 now: open.spotify.com/show/5iALGRluQ…